Inhibition of erythroid progenitor cells by anti-kell antibodies in fetal alloimmune anemia

New England Journal of Medicine

Volumn 338, Issue 12, 1998, Pages 798-803

  Vaughan, Janet I ^a   Manning, Monica ^b   Warwick, Ruth M ^a   Letsky, Elizabeth A ^a   Murray, Neil A ^b   Roberts, Irene A G ^b  

^a Inst of Obstetrics and Gynaecology

^b IMPERIAL COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN G ANTIBODY; IMMUNOGLOBULIN M ANTIBODY; MONOCLONAL ANTIBODY;

ALLOIMMUNIZATION; ARTICLE; BLOOD GROUP KELL SYSTEM; BURST FORMING UNIT E; CLINICAL ARTICLE; CONTROLLED STUDY; ERYTHROPOIESIS; HEMATOPOIETIC STEM CELL; HEMOLYTIC ANEMIA; HUMAN; HUMAN CELL; NEWBORN HEMOLYTIC DISEASE; PRIORITY JOURNAL; UMBILICAL CORD BLOOD;

ANEMIA, HEMOLYTIC, AUTOIMMUNE; ANTIBODIES, MONOCLONAL; CELL DIVISION; ERYTHROBLASTOSIS, FETAL; ERYTHROID PROGENITOR CELLS; ERYTHROPOIESIS; FEMALE; FETAL BLOOD; HEMATOPOIETIC STEM CELLS; HUMANS; INFANT, NEWBORN; ISOANTIBODIES; KELL BLOOD-GROUP SYSTEM; PREGNANCY; RH-HR BLOOD-GROUP SYSTEM; SEVERITY OF ILLNESS INDEX;

EID: 0032546227     PISSN: 00284793     EISSN: None     Source Type: Journal    
DOI: 10.1056/NEJM199803193381204     Document Type: Article

References (24)

1. Lee S, Zambas ED, Marsh WL, Redman CM. The human Kell blood group gene maps to chromosome 7q33 and its expression is restricted to crythroid cells. Blood 1993;81:2804-9.
2. Redman CM, Lee S. Kell blood group system and the McLeod syndrome. In: Cartron J-P, Rouger P, eds. Blood cell biochemistry. Vol. 6. Molecular basis of human blood group antigens. New York: Plenum Press, 1995:227-42
3. McGinniss MH, Dean A. Expression of red cell antigens by K562 human leukemia cells before and after induction of hemoglobin synthesis by hemin. Transfusion 1985;25:105-9.
4. Jaber A, Loirat MJ, Willem C, Bloy C, Cartron JP, Blanchard D. Characterization of murine monoclonal antibodies directed against the Kell blood group glycoprotein. Br J Haematol 1991;79:311-5
5. Mollison PL, Engelfriet CP, Contreras M. Blood transfusion in clinical medicine. 9th ed. Oxford, England: Blackwell Scientific, 1993:581-2
6. Vaughan JI, Warwick R, Welch CR, Letsky KA. Anti Kell in pregnancy. Br J Obstet Gynaecol 1991;98:944-5.
7. Vaughan JI, Warwick R, Letsky E, Nicolini U, Rodeck CH, Fisk NM. Erythropoietic suppression in fetal anemia because of Kell alloimmunization. Am J Obstet Gynecol 1994;171:247-52.
8. Farr V, Gray E. Pregnancy outcome in mothers who develop Kell antibodies. Scott Med J 1988;33:300-3.
9. Leggat HM, Gibson JM, Barron SL, Reid MM. Anti-Kell in pregnancy. Br J Obstet Gynaecol 1991;98:162-5.
10. Weiner CP, Widness JA. Decreased fetal erythropoiesis and hemolysis in Kell hemolytic anemia. Am J Obstet Gynecol 1996;174:547-51.
11. Nicolaides KH, Rodeck CH, Mibashan RS, Kemp JR. Have Liley charts outlived their usefulness? Am J Obstet Gynecol 1986;155:90-4.
12. Bowman JM, Pollock JM, Manning FA, Harman CR, Menticoglou S. Maternal Kell blood group alloimmumzation. Obstet Gynecol 1992;79: 239-44.
13. Murray NA, Roberts LAG. Circulating megakaryocytes and their progenitors (BFU MK and CFU-MK) in term and pre-term neonates. Br J Haematol 1995;89:41-6.
14. Contreras M, Knight RC. General approach to blood transfusion and immunohaematology. In: Chanarin I, ed. Laboratory haematology: an account of laboratory techniques. Edinburgh, Scotland: Churchill Livingstone, 1987:403-4.
15. Greeer IA, Lyall F, Perera T, Boswell F, Macara I.M. Increased concentrations of cytokines interleukin-6 and interleukin-1 receptor antagonist in plasma of women with preeclampsia: a mechanism for endothelial dysfunction. Obstet Gynecol 1994;84:937-40
16. Marsh WL, Redman CM. The Kell blood group system: a review. Transfusion 1990;30:158-67.
17. Lee S, Zambas HD, Green ED, Redman C. Organization of the gene encoding the human Kell blood group protein. Blood 1995;85:1364-70.
18. Lee S, Zambas ED, Marsh WL, Redman CM. Molecular cloning and primary structure of Kell blood group protein. Proc Natl Acad Sci U S A 1991;88:6353 7.
19. Jongeneel CV, Bouvier J, Bairoch A. A unique signature identities a family of zinc dependent metallopeptidases. FEBS Lett 1989;242:211-4.
20. Shipp MA, Vijayaraghavan J, Schmidt EV, et al. Common acute lymphoblastic leukemia antigen (CALLA) is active neutral endopeptidase 24.11 ("enkephalinase"): direct evidence by cDNA transfection analysis. Proc Natl Acad Sci USA 1989;86:297-301.
21. Wu Q, Lahti JM, Air GM, Burrows PD, Cooper MD. Molecular cloning of the murine BP-1/6C3 antigen: a member of the zinc-dependent metallopeptidase family. Proc Natl Acad Sci U S A 1990;87:993-7.
22. Lee S, Wu X, Reid M, Zelinski T, Redman C. Molecular basis of the Kell (K1) phenotype. Blood 1995;85:912-6.
23. Kenny AJ, O'Hare MJ, Gusterson BA. Cell-surface peptidases as modulators of growth and differentiation. Lancet 1989;2:785-7.
24. Avent ND, Martin PG. Kell typing by allele specific PCR (ASP). Br J Haematol 1996,93:728-30.